| P50 | author | Juan M. Irache | Q43161954 |
| P2093 | author name string | J de Souza | |
| | A I Camacho | |
| | C Gamazo | |
| | S Sánchez-Gómez | |
| P2860 | cites work | Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3 | Q28259057 |
| | The CD40 antigen and its ligand | Q28286277 |
| | Toll-like receptor control of the adaptive immune responses | Q29547305 |
| | Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants. | Q30404206 |
| | Shigellosis: an old disease in new clothes? | Q33257255 |
| | Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice. | Q33282108 |
| | Polymer chemistry influences monocytic uptake of polyanhydride nanospheres | Q33383038 |
| | The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells | Q33518453 |
| | Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model | Q33983350 |
| | Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity | Q34491896 |
| | Polyanhydrides: an overview. | Q34971379 |
| | Decreasing Shigellosis-related Deaths withoutShigellaspp.–specific Interventions, Asia | Q35804868 |
| | Broadly protective Shigella vaccine based on type III secretion apparatus proteins | Q35805439 |
| | Inferences, questions and possibilities in Toll-like receptor signalling | Q35829752 |
| | Mucosal adjuvants | Q36055990 |
| | Live-attenuated Shigella vaccines | Q36689023 |
| | Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? | Q36703588 |
| | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 |
| | Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. | Q36966451 |
| | Polyanhydride microparticles enhance dendritic cell antigen presentation and activation. | Q37010485 |
| | What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? | Q37634790 |
| | Inactivated and subunit vaccines to prevent shigellosis | Q37640115 |
| | Designing polymeric particles for antigen delivery | Q37808118 |
| | Defending the mucosa: adjuvant and carrier formulations for mucosal immunity | Q37867814 |
| | Particulate vaccines: on the quest for optimal delivery and immune response. | Q37875382 |
| | New insights in mucosal vaccine development. | Q37956429 |
| | Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis | Q40211202 |
| | Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles | Q40327793 |
| | Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain | Q41480678 |
| | Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation | Q42117985 |
| | Bioadhesive properties of Gantrez nanoparticles | Q46897266 |
| | Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine | Q46938617 |
| | Development of a novel vaccine delivery system based on Gantrez nanoparticles. | Q51117082 |
| | Porin of Shigella dysenteriae activates mouse peritoneal macrophage through Toll-like receptors 2 and 6 to induce polarized type I response. | Q53619852 |
| | Toxicity studies of poly(anhydride) nanoparticles as carriers for oral drug delivery | Q84230263 |
| | Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators | Q84301195 |
| | Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice | Q84938205 |
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| | Shigella flexneri | Q1644417 |
| P304 | page(s) | 3288-3294 | |
| P577 | publication date | 2013-05-31 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice | |
| P478 | volume | 31 | |